Free Access
Med Sci (Paris)
Volume 27, Number 12, Décembre 2011
Page(s) 1064 - 1066
Section Nouvelles
Published online 23 December 2011
  1. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009 ; 324 : 930–935. [CrossRef] [PubMed] [Google Scholar]
  2. Gu TP, Guo F, Yang H, et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011 ; 477 : 606–610. [CrossRef] [PubMed] [Google Scholar]
  3. Dawlaty MM, Ganz K, Powell BE, et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 2011 ; 9 : 166–175. [CrossRef] [PubMed] [Google Scholar]
  4. Nabel CS, Kohli RM. Molecular biology. Demystifying DNA demethylation. Science 2011 ; 333 : 1229–1230. [CrossRef] [PubMed] [Google Scholar]
  5. Guo JU, Su Y, Zhong C, et al. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond. Cell Cycle 2011 ; 10 : 2662–2668. [CrossRef] [PubMed] [Google Scholar]
  6. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 2007 ; 67 : 946–950. [CrossRef] [PubMed] [Google Scholar]
  7. Münzel M, Globisch D, Carell T. 5-Hydroxymethylcytosine, the sixth base of the genome. Angew Chem Int Ed Engl 2011 ; 50 : 6460–6468. [CrossRef] [PubMed] [Google Scholar]
  8. Bernard OA, Delhommeau F, Fontenay M, Vainchenker W. Mutations du gène TET2 dans les hémopathies myéloïdes humaines. Med Sci (Paris) 2009 ; 25 : 785–788. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Moran-Crusio K, Reavie L, Shih A, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011 ; 20 : 11–24. [CrossRef] [PubMed] [Google Scholar]
  10. Quivoron C, Couronne L, Della Valle V, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011 ; 20 : 25–38. [CrossRef] [PubMed] [Google Scholar]
  11. Li Z, Cai X, Cai C, et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 2011 ; 118 : 4509–4518. [CrossRef] [PubMed] [Google Scholar]
  12. Ko M, Bandukwala HS, An J, et al. Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci USA 2011 ; 108 : 14566–14571. [CrossRef] [Google Scholar]
  13. Viguie F, Aboura A, Bouscary D, et al. Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? Leukemia 2005 ; 19 : 1411–1415. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.